FDA keeps the faith in surrogate endpoints

FDA keeps the faith in surrogate endpoints

Source: 
EP Vantage
snippet: 

The US regulator granted 14 accelerated approvals in 2019, fewer than in the previous two years, and the sector remains slow at conversions.